Lineage Cell Therapeutics Ownership & Insider Activity

Lineage Cell Therapeutics (LCTX) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 5.8% of shares outstanding. Institutional investors hold 16.1%.

Shares Outstanding

252.907M

Shares Float

152.472M

Insider Shares Owned

14.661M

Insider % Owned

5.8%

Institutional Shares Held

40.795M

Institutional % Held

16.1%

Ownership Breakdown

Net Insider Activity by Month

Lineage Cell Therapeutics Insider Transactions (Last 6 Months)

No insider filings in the last 6 months.